Your browser doesn't support javascript.
loading
Effect of Urinary Kallidinogenase on Transforming Growth Factor-ß1 and High-Sensitivity C-Reactive Protein Expression in Rat Focal Cerebral Ischemic Injury.
Dong, Ting-Fang; Lv, Hai-Xia; Niu, Xiao-Lu; Gui, Yong-Kun; Zhang, Ping; Yan, Hai-Qing; Li, Tong.
Afiliación
  • Dong TF; Department of Pharmacy, The First Afiliated Hospital of Xinxiang Medical College, Weihui, Henan, China (mainland).
  • Lv HX; School of Pharmacy, Xinxiang Medical University, Xinxiang, Henan, China (mainland).
  • Niu XL; Department of Neurology, The First Afiliated Hospital of Xinxiang Medical College, Weihui, Henan, China (mainland).
  • Gui YK; Department of Neurology, The First Afiliated Hospital of Xinxiang Medical College, Weihui, Henan, China (mainland).
  • Zhang P; Department of Neurology, The First Afiliated Hospital of Xinxiang Medical College, Weihui, Henan, China (mainland).
  • Yan HQ; Department of Neurology, The First Afiliated Hospital of Xinxiang Medical College, Weihui, Henan, China (mainland).
  • Li T; Department of Neurology, The First Afiliated Hospital of Xinxiang Medical College, Weihui, Henan, China (mainland).
Med Sci Monit ; 22: 2852-8, 2016 Aug 13.
Article en En | MEDLINE | ID: mdl-27521289
ABSTRACT
BACKGROUND In this study we investigated the effect of urinary kallidinogenase (UK) on transforming growth factor beta 1 (TGF-ß1) expression in brain tissue. We also explored the neuroprotective mechanism of UK against ischemic injury by measuring serum high-sensitivity C-reactive protein (hs-CRP) level changes after rat cerebral ischemic injury. MATERIAL AND METHODS The rat middle cerebral artery ischemia/reperfusion model was established using the suture method. Sprague-Dawley rats were randomly divided into 3 groups treatment, Gegen control, and blank control. Each group was subsequently divided into 5 subgroups according to time (6, 12, 24, 48, and 72 h). Rats in the treatment group were administered UK as treatment. TGF-ß1 expression was observed at each time point using SABC and immunohistochemical staining methods to estimate cerebral infarct volume percentage. Serum hs-CRP levels were also measured. RESULTS TGF-ß1 protein expression in ischemic brain tissues of the treatment group significantly increased at each time point (P<0.01) compared with both control groups. Treatment group serum hs-CRP levels significantly decreased at each time point (P<0.05) compared with both control groups. CONCLUSIONS UK exerts a neuroprotective effect by upregulating TGF-ß1 expression and inhibiting excessive inflammatory responses.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Calicreínas / Isquemia Encefálica / Factor de Crecimiento Transformador beta1 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Med Sci Monit Asunto de la revista: MEDICINA Año: 2016 Tipo del documento: Article Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Calicreínas / Isquemia Encefálica / Factor de Crecimiento Transformador beta1 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Med Sci Monit Asunto de la revista: MEDICINA Año: 2016 Tipo del documento: Article Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA